Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial (Q33997418)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial |
scientific article |
Statements
1 reference
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial (English)
1 reference
Nancy A Rigotti
1 reference
Douglas E Jorenby
1 reference
J Taylor Hays
1 reference
Salomon Azoulay
1 reference
Eric J Watsky
1 reference
Kathryn E Williams
1 reference
Clare B Billing
1 reference
Jason Gong
1 reference
Karen R Reeves
1 reference
Varenicline Phase 3 Study Group
1 reference
1 July 2006
1 reference
1 reference
296
1 reference
56-63
1 reference
Identifiers
1 reference
1 reference